Before administration to patients, parenteral medicines must be in a ready-to-administer (RTA) form, presented at the required concentration and volume, in the final container (syringe, infusion bag or elastomeric device) for administration. Unless provided by the marketing authorisation holder in an RTA form, parenteral medicines have to be reconstituted.
The quality of reconstituted medicines should ideally be the same, regardless of where the reconstitution takes place, in the clinical area – for example, on a ward or in theatre – or within a pharmacy. Although guidance on reconstitution is available in some countries, this is not the case across all member states of the Council of Europe.
In June 2016, the Council of Europe adopted Resolution CM/Res(2016)2 on good reconstitution practices in healthcare establishments for medicinal products for parenteral use with a view to improving the safety of patients receiving reconstituted injectable medicines, and enabling risk reduction in Europe.
This webinar will provide some practical examples of how the provisions set out in the above resolution can be transposed into national legislation and implemented in a hospital pharmacy setting. It will also highlight some of the challenges that may affect the implementation process and outline strategies to overcome them. Finally, it will provide the nurses’ perspective on the reconstitution process and their co-operation with hospital pharmacists.
The webinar will take place on 16 June, from 10:30 a.m. to 12:00 p.m. (CEST, Paris, France). Participants will also get the opportunity to ask questions live to the speakers.
- Download the preliminary programme (subject to change)
More information on Pharmaceutical Practices and Pharmaceutical Care
Who should attend?
This webinar is for healthcare professionals, in particular pharmacists working in hospital pharmacies, nurses and physicians. It will also be of interest to healthcare and patient associations, as well as national competent authorities and ministries of health.
Those looking to learn more about the EDQM and its role in setting quality and safety standards in pharmaceutical practices and pharmaceutical care should also find it useful.
No special software is necessary for the webinar. If you wish to connect to audio using VoIP (Voice over Internet Protocol) you will need a fast internet connection, a microphone and speakers. A USB headset is recommended. The VoIP connection is free.
You are strongly advised to consult your IT Department to ensure your computer can receive the webinar and that the following domain names are neither rejected nor blocked as spam, otherwise you will not receive the link to connect to the webinar: @gotowebinar.com and @care.gotowebinar.com.